Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis

Paediatric Anaesthesia

Volumn 17, Issue 7, 2007, Pages 637-646

  Woloszczuk Gebicka, Bogumila ^a   Wyska, Elzbieta ^b   Grabowski, Tomasz ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Centre of Pharmacokinetics Research FILAB   (Poland)

Author keywords

Anesthetics; Inhalational: sevoflurane; Pediatric: pharmacokinetic pharmacodynamic modeling; Pharmacodynamics: synergism

Indexed keywords

FENTANYL; MIDAZOLAM; NITROUS OXIDE; ROCURONIUM; SEVOFLURANE; THIOPENTAL;

ANESTHESIA; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; ELECTROCHEMICAL DETECTION; ELECTROMYOGRAM; FEMALE; HAND MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTUBATION; MALE; MUSCLE TETANIC CONTRACTION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; ULNAR NERVE;

ANDROSTANOLS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; BODY TEMPERATURE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FENTANYL; HEART RATE; HUMANS; METHYL ETHERS; MONITORING, INTRAOPERATIVE; MUSCLE RELAXATION; MUSCLE, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE; SYNAPTIC TRANSMISSION;

EID: 34250363173     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2006.02181.x     Document Type: Article

References (32)

1. Tsuneki H, Kimura I, Dezaki K et al. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 1995 196 : 13 16.
2. Bowman WC, Webb SN. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat. Clin Exp Pharmacol Physiol 1976 3 : 545 555.
3. Bowman WC, Marshall IG, Gibb AJ et al. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci 1988 9 : 16 20.
4. Faria M, Oliveira L, Timoteo MA et al. Blockade of neuronal facilitatory nicotinic receptors containing alpha3beta2 subunits contribute to tetanic fade in the rat isolated diaphragm. Synapse 2003 49 : 77 88.
5. Chiodini F, Charpantier E, Muller D et al. Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine. Anesthesiology 2001 94 : 643 651.
6. Lowry DW, Mirakhur RK, McCarthy GJ et al. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998 87 : 936 940.
7. Xue FS, Liao X, Tong SY et al. Dose-response and time-course of the effect of rocuronium bromide during sevoflurane anaesthesia. Anaesthesia 1998 53 : 25 30.
8. Wulf H, Ledowski T, Linstedt U et al. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998 45 : 526 532.
9. Woloszczuk-Gebicka B, Lapczynski T, Wierzejski W. The influence of halothane, isoflurane and sevoflurane on rocuronium infusion in children. Acta Anaesthesiol Scand 2001 45 : 73 77.
10. Reid JE, Breslin DS, Mirakhur RK et al. Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anaesth 2001 8 : 351 355.
11. Woloszczuk-Gebicka B, Wyska E, Grabowski T et al. Pharmacokinetic- pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anaesthesia in children. Pediatr Anesth 2006 16 : 761 768.
12. Mori T, Zhao X, Zuo Y et al. Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol Pharmacol 2001 59 : 732 743.
13. Woloszczuk-Gebicka B. Influence of halothane on the train-of-four fade after atracurium in children. Br J Anaesth 1990 65 : 540 541.
14. Katoh T, Ikeda K. Minimum alveolar concentration of sevoflurane in children. Br J Anaesth 1992 68 : 139 144.
15. Viby-Mogensen J, Engbaek J, Eriksson LI et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996 40 : 59 74.
16. Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 2nd edn. Stockholm : Swedish Pharmaceutical Press 770.
17. Sheiner LB, Stanski DR, Vozeh S et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979 25 : 358 371.
18. D'Argenio DZ, Schumitzky A. ADAPT II User's Guide. Los Angeles, CA : Biomedical Simulation Resource, 1997.
19. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997 86 : 765 771.
20. Morita A, Kurosaki TA, Tsukagoshi D et al. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block. Can J Anaesth 1996 43 : 799 805.
21. Morita T, Kurosaki D, Tsukagoshi H et al. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia. Anaesthesia 1997 52 : 538 543.
22. Izawa HA, Takeda JA, Fukushima K. Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man. Masui Jap J Anesth 1997 46 : 177 183.
23. Bock M, Klippel K, Nitsche B et al. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000 84 : 43 47.
24. Kumar N, Mirakhur RK, Symington MJ et al. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia. Br J Anaesth 1996 77 : 488 491.
25. Baurain MJ, d'Hollander AA, Melot C et al. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991 74 : 474 478.
26. Meretoja OA, Wirtavuori K, Taivainen T et al. Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 1996 76 : 235 238.
27. Vermeyen KM, Hoffmann VL, Saldien V. Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model. Br J Anaesth 2003 90 : 183 188.
28. McCoy EP, Mirakhur RK, Maddineni VR et al. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia. Br J Anaesth 1996 76 : 29 33.
29. O'Kelly B, Fisset P, Meistelman C et al. Pharmacokinetics of rocuronium bromide in paediatric patients. Eur J Anaesthesiol (Suppl.) 1994 9 : 57 58.
30. Paul M, Fokt RM, Kindler CH et al. Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg 2002 95 : 362 367.
31. Dragne A, Varin F, Plaud B et al. Rocuronium pharmacokinetic- pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth 2002 49 : 353 360.
32. Warwick NR, Graham GG, Torda TA. Pharmacokinetic analysis of the effect of vecuronium in surgical patients: pharmacokinetic and pharmacodynamic modeling without plasma concentrations. Anesthesiology 1998 88 : 874 884.